(Q42799314)

7 November 2017

title

Adipogenic differentiating agents regulate expression of fatty acid binding protein and CD36 in the J744 macrophage cell line (English)

1 reference

7 November 2017

0 references

Li Sun

1

1 reference

7 November 2017

Andrew C Nicholson

2

1 reference

7 November 2017

David P Hajjar

3

1 reference

7 November 2017

Antonio M Gotto

4

1 reference

7 November 2017

Jihong Han

5

1 reference

7 November 2017

publication date

16 July 2003

1 reference

Journal of Lipid Research

7 November 2017

published in

1 reference

7 November 2017

volume

44

1 reference

7 November 2017

issue

10

1 reference

7 November 2017

page(s)

1877-1886

1 reference

The fatty acid transport function of fatty acid-binding proteins

7 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Physiological properties and functions of intracellular fatty acid-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Intracellular lipid-binding proteins and their genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Structural properties of the adipocyte lipid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

21 January 2018

Regulating adipogenesis

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Peroxisome proliferator activated receptor gamma, CCAAT/enhancer-binding protein alpha, and cell cycle status regulate the commitment to adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Induction of peroxisome proliferator-activated receptor gamma during the conversion of 3T3 fibroblasts into adipocytes is mediated by C/EBPbeta, C/EBPdelta, and glucocorticoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Role of the CCAAT enhancer binding proteins (C/EBPs) in adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

PPARgamma induces the insulin-dependent glucose transporter GLUT4 in the absence of C/EBPalpha during the conversion of 3T3 fibroblasts into adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Expression of the CD36 homolog (FAT) in fibroblast cells: effects on fatty acid transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

PPARgamma promotes monocyte/macrophage differentiation and uptake of oxidized LDL

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Lack of macrophage fatty-acid-binding protein aP2 protects mice deficient in apolipoprotein E against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

PPARgamma activation induces the expression of the adipocyte fatty acid binding protein gene in human monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Regulation of peroxisome proliferator-activated receptor-gamma-mediated gene expression. A new mechanism of action for high density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Adipocytes recognize and degrade oxidized low density lipoprotein through CD36.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Uncoupling of obesity from insulin resistance through a targeted mutation in aP2, the adipocyte fatty acid binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Altered insulin secretion associated with reduced lipolytic efficiency in aP2-/- mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Molecular control of immune/inflammatory responses: interactions between nuclear factor-kappa B and steroid receptor-signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Expression of the differentiation-induced gene for fatty acid-binding protein is activated by glucocorticoid and cAMP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

cAMP activation of CAAT enhancer-binding protein-beta gene expression and promoter I of acetyl-CoA carboxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Finkel-Biskis-Reilly osteosarcoma virus v-Fos inhibits adipogenesis and both the activity and expression of CCAAT/enhancer binding protein alpha, a key regulator of adipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Mechanism of regulation of the 422(aP2) gene by cAMP during preadipocyte differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Beta-adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Inhibition of adipogenesis through MAP kinase-mediated phosphorylation of PPARgamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Insulin- and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Transforming growth factor-beta1 (TGF-beta1) and TGF-beta2 decrease expression of CD36, the type B scavenger receptor, through mitogen-activated protein kinase phosphorylation of peroxisome proliferator-activated receptor-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Role of inflammatory responses in initiation of atherosclerosis: effects of anti-inflammatory drugs on cuff-induced leukocyte accumulation and intimal thickening of rabbit carotid artery

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Role of macrophage-expressed adipocyte fatty acid binding protein in the development of accelerated atherosclerosis in hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M300084-JLR200

10.1194/JLR.M300084-JLR200

21 January 2018

Identifiers

DOI

1 reference

7 November 2017

1 reference